Merck (MRK) Tops Q2 EPS by 19c; Raises and Narrows FY Sales Guidance, Narrows EPS

Merck (NYSE: MRK) reported Q2 EPS of $1.87, $0.19 better than the analyst estimate of $1.68. Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $13.83 billion.

GUIDANCE:

Merck sees FY2022 EPS of $7.25-$7.35, versus the consensus of $7.36. Merck sees FY2022 revenue of $57.5-58.5 billion, versus the consensus of $58.1 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance